Lawrence Cohen

HemoSense, Inc. develops and manufactures easy-to-use, handheld blood coagulation systems for use by patients and healthcare professionals in the management of warfarin medication. The company was founded in 1997 and is headquartered in San Jose, CA.

SenGenix, Inc. develops point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors. The firm’s FRS-based strips are used to test various types of clinical analytes, including electrolytes, metabolites, drugs, proteins and cells. The company was founded in 2012 and is headquartered in Durham, NC.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ.

Meridian Bioscience Israel Ltd. engages in the development, manufacturing, marketing, and distribution of diagnostic and life science products. It offers its solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies. The company was founded by Uri Geiger on April 11, 2006 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.

Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY.